v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
Mar. 31, 2026
Sep. 30, 2025
Current Assets:    
Cash and cash equivalents $ 14,255,720 $ 2,284,933
Prepaid expenses and other current assets 614,472 189,549
Advances to supplier 98,250 98,250
Due from related party 147,500 120,000
Total Current Assets 15,115,942 2,692,732
Investment in securities designated for sale 281 281
Equity method investment 2,773,616
Notes receivable 3,476,245
Property and equipment, net 60,121
 Other non-current assets 360,000
Intangible assets, net 113,915,787
Total Assets 135,701,992 2,693,013
Current liabilities:    
Accounts payable and accrued expenses 4,284,917 3,917,834
Customer deposit 108,006 108,006
Deferred revenue 350,000
Income taxes payable 1,043,932 994,704
Excise tax payable 1,002,860 943,039
Promissory notes, net of unamortized debt issuance cost 21,939,203 1,003,995
Due to related parties 2,100,316 2,434,492
Convertible notes payable, net of unamortized debt issuance cost 5,625,883 4,861,390
Stock based compensation liability 375,000
Deferred underwriters’ discount 225,000 225,000
Total Current Liabilities 37,055,117 14,488,460
Total Liabilities 37,055,117 14,488,460
Stockholders’ Equity (Deficit)    
Preferred stock, par value $0.01, 10,000,000 shares authorized; no shares issued or outstanding
Common stock, par value $0.01, 150,000,000 shares authorized; 20,347,137 and 14,521,094 shares issued and outstanding at March 31, 2026 and September 30, 2025, respectively. 203,470 145,211
Shares to be issued related to acquisition, par value $0.01, 7,000,000 and 0 shares at March 31, 2026 and September 30, 2025, respectively. 66,990,000
Additional paid-in capital 66,408,319 3,168,248
Accumulated deficit (34,954,914) (15,108,906)
Total Stockholders’ Equity (Deficit) 98,646,875 (11,795,447)
Total Liabilities and Stockholders’ Equity (Deficit) $ 135,701,992 $ 2,693,013